Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine

Margie H Danchin, Carl D Kirkwood, Katherine J Lee, Ruth F Bishop, Emma Watts, Frances A Justice, Vanessa Clifford, Donna Cowley, James Peter Buttery, Julie E Bines

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)

Abstract

RV3 is a human neonatal virus strain (G3P[6]) that has been associated with asymptomatic neonatal infection and replicates well in the infant gut. RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.
Original languageEnglish
Pages (from-to)2610 - 2616
Number of pages7
JournalVaccine
Volume31
Issue number23
DOIs
Publication statusPublished - 2013

Cite this

Danchin, M. H., Kirkwood, C. D., Lee, K. J., Bishop, R. F., Watts, E., Justice, F. A., ... Bines, J. E. (2013). Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine. Vaccine, 31(23), 2610 - 2616. https://doi.org/10.1016/j.vaccine.2013.04.008
Danchin, Margie H ; Kirkwood, Carl D ; Lee, Katherine J ; Bishop, Ruth F ; Watts, Emma ; Justice, Frances A ; Clifford, Vanessa ; Cowley, Donna ; Buttery, James Peter ; Bines, Julie E. / Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine. In: Vaccine. 2013 ; Vol. 31, No. 23. pp. 2610 - 2616.
@article{1743be66af6b46669c36540571b1d329,
title = "Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine",
abstract = "RV3 is a human neonatal virus strain (G3P[6]) that has been associated with asymptomatic neonatal infection and replicates well in the infant gut. RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.",
author = "Danchin, {Margie H} and Kirkwood, {Carl D} and Lee, {Katherine J} and Bishop, {Ruth F} and Emma Watts and Justice, {Frances A} and Vanessa Clifford and Donna Cowley and Buttery, {James Peter} and Bines, {Julie E}",
year = "2013",
doi = "10.1016/j.vaccine.2013.04.008",
language = "English",
volume = "31",
pages = "2610 -- 2616",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier",
number = "23",

}

Danchin, MH, Kirkwood, CD, Lee, KJ, Bishop, RF, Watts, E, Justice, FA, Clifford, V, Cowley, D, Buttery, JP & Bines, JE 2013, 'Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine', Vaccine, vol. 31, no. 23, pp. 2610 - 2616. https://doi.org/10.1016/j.vaccine.2013.04.008

Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine. / Danchin, Margie H; Kirkwood, Carl D; Lee, Katherine J; Bishop, Ruth F; Watts, Emma; Justice, Frances A; Clifford, Vanessa; Cowley, Donna; Buttery, James Peter; Bines, Julie E.

In: Vaccine, Vol. 31, No. 23, 2013, p. 2610 - 2616.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine

AU - Danchin, Margie H

AU - Kirkwood, Carl D

AU - Lee, Katherine J

AU - Bishop, Ruth F

AU - Watts, Emma

AU - Justice, Frances A

AU - Clifford, Vanessa

AU - Cowley, Donna

AU - Buttery, James Peter

AU - Bines, Julie E

PY - 2013

Y1 - 2013

N2 - RV3 is a human neonatal virus strain (G3P[6]) that has been associated with asymptomatic neonatal infection and replicates well in the infant gut. RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.

AB - RV3 is a human neonatal virus strain (G3P[6]) that has been associated with asymptomatic neonatal infection and replicates well in the infant gut. RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.

UR - http://www.sciencedirect.com/science/article/pii/S0264410X13004271

U2 - 10.1016/j.vaccine.2013.04.008

DO - 10.1016/j.vaccine.2013.04.008

M3 - Article

VL - 31

SP - 2610

EP - 2616

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 23

ER -

Danchin MH, Kirkwood CD, Lee KJ, Bishop RF, Watts E, Justice FA et al. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine. Vaccine. 2013;31(23):2610 - 2616. https://doi.org/10.1016/j.vaccine.2013.04.008